Drawing for JUDI BY AG MEDNET

USPTO serial 97137192

JUDI BY AG MEDNET

Reviewed by CopyMark Law Group

Reg. 7009701Status 700Registered
Filing date
Status date
Registration date
Mar 28, 2023
Examiner
LOVELACE, JAMES B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with JUDI BY AG MEDNET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael S. Palmisciano

Michael S. Palmisciano Sullivan & Worcester LLP1251 Avenue of the AmericasNew York, NY 10020United States

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SaaS) services featuring software for providing clinical trial workflow, content and process management, data analytics, data visualization, data optimization and collecting, analyzing and managing clinical trial data and processes; software as a service (SaaS) services featuring software for enterprise level content management in the field of life sciences; providing online, non-downloadable cloud-based software and web applications for clinical trial collaboration for pharmaceutical, biotechnology and medical device companies and contract research organizations (CROs)ACTIVEOct 1, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 24, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 24, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 28, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 28, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 19, 2023ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 7, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 11, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 11, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 21, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Sep 6, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 6, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 6, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 1, 2022DOCKASSIGNED TO EXAMINER—
Nov 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 25, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance